Bian Guangjun, Zhao Wei, Zhang Li
Department of Imaging, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu Province, China.
Department of Orthopedic, Weifang Medical University, Weifang, Shandong, China.
Ann Med. 2025 Dec;57(1):2524091. doi: 10.1080/07853890.2025.2524091. Epub 2025 Jul 11.
Intra-articular platelet-rich plasma (PRP) injections have been the subject of extensive study in knee osteoarthritis (OA), yet their effectiveness in hip OA has not been explored.
To assess and evaluate the therapeutic effectiveness of autologous PRP and hyaluronic acid (HA) in treating hip OA.
Intra-articular injections were administered to 150 patients with hip osteoarthritis, and the patients were divided into two groups: PRP and HA. The evaluation of clinical outcomes was conducted using the Harris Hip Score (HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Visual Analogue Scale (VAS) at 3, 6, and 12 months. Outcomes were compared using regression analysis, repeated measure ANOVA, and Pearson correlation test.
The PRP group showed greater improvements in all scores ( < 0.05) compared to HA. PRP injection significantly reduced VAS and WOMAC scores [VAS score (MD 2.238, 95% CI 0.065-3.21) and WOMAC score (MD 1.033, 95% CI 0.06-1.526)], while HHS score increased (MD 1.02, 95% CI 0.06-1.126). IL-10 and VAS score showed a moderate correlation in the PRP group ( = 0.591). While statistical significance is indicated by the results, it is suggested that the changes in scores are small and may not be representative of any clinical significance.
It has been demonstrated by the findings of this study that pain and joint discomfort may be decreased by the administration of PRP injections, which may aid in the management of hip OA. However, there was no clinical difference between PRP and HA treatments.
关节内注射富含血小板血浆(PRP)已成为膝关节骨关节炎(OA)广泛研究的课题,但其在髋关节OA中的有效性尚未得到探索。
评估自体PRP和透明质酸(HA)治疗髋关节OA的疗效。
对150例髋关节骨关节炎患者进行关节内注射,并将患者分为两组:PRP组和HA组。在3、6和12个月时使用Harris髋关节评分(HHS)、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)以及视觉模拟量表(VAS)对临床结果进行评估。使用回归分析、重复测量方差分析和Pearson相关性检验比较结果。
与HA组相比,PRP组在所有评分中均显示出更大的改善(<0.05)。PRP注射显著降低了VAS和WOMAC评分[VAS评分(MD 2.238,95%CI 0.065 - 3.21)和WOMAC评分(MD 1.033,95%CI 0.06 - 1.526)],而HHS评分升高(MD 1.02,95%CI 0.06 - 1.126)。PRP组中IL - 10与VAS评分呈中度相关(=0.591)。虽然结果显示有统计学意义,但提示评分变化较小,可能不具有任何临床意义。
本研究结果表明,PRP注射可减轻疼痛和关节不适,这可能有助于髋关节OA的管理。然而,PRP和HA治疗之间没有临床差异。